/PRNewswire/ The "Alzheimer s Disease - Market Insight, Epidemiology And Market Forecast - 2032" report has been added to ResearchAndMarkets.com s offering..
New York, USA, Aug. 02, 2023 (GLOBE NEWSWIRE) Alzheimer's Disease Market Predicted to Surge at a CAGR of 20% During the Study Period (2019–2032), Assesses DelveInsight The Alzheimer's disease market size is
An experimental tau aggregation inhibitor significantly reduced tau, an established biomarker of neurodegeneration, which correlated with changes in cognitive test scores.
Although the novel tau aggregation inhibitor hydromethylthionine mesylate did not reach its coprimary endpoints, investigators insist there s more to the story ― especially with the control agent used.